» Articles » PMID: 36798725

The Role of Aldosterone and Ideal Cardiovascular Health in Incident Diabetes: The Jackson Heart Study

Abstract

Background: Greater attainment of ideal cardiovascular health (ICH) and lower serum aldosterone are associated with lower diabetes risk. Higher levels of ICH are associated with lower aldosterone. The mediational role of aldosterone in the association of ICH with incident diabetes remains unexplored. Thus, we examined the mediational role of aldosterone in the association of 5 ICH components (smoking, diet, physical activity, body mass index [BMI], and cholesterol) with incident diabetes. Additionally, we investigated the mediational role of glucose and blood pressure (BP) in the association of aldosterone with incident diabetes in an African American (AA) cohort.

Methods: We conducted a prospective cohort analysis among AA adults, aged 21-94 years, in the Jackson Heart Study. Data on ICH, aldosterone, and cardiometabolic risk factors were collected at exam 1 (2000-2004). Diabetes (fasting glucose ≥ 126 mg/dL, physician diagnosis, use of diabetes drugs, or glycated hemoglobin ≥ 6.5%) was assessed at exams 1 through 3 (2009-2012). ICH metrics were defined by American Heart Association 2020 goals for smoking, dietary intake, physical activity, BMI, total cholesterol, BP and glucose. The number of ICH metrics attained at exam 1, excluding BP and fasting glucose, were summed (0-2, vs. 3+). R Package was used to examine: 1) The mediational role of aldosterone in the association of ICH with incident diabetes; and 2) the mediational role of BP and glucose in the association of aldosterone with incident diabetes.

Results: Among 2,791 participants (mean age: 53±12, 65% female) over a median of 7.5 years, there were 497 incident diabetes cases. Risk of incident diabetes was 37% (HR: 0.63, 95%CI: 0.47, 0.84) lower in 3+ ICH category compared to 0-2 ICH category. Aldosterone mediated 6.98% (95% CI: 1.8%, 18.0%) of the direct effect of ICH on incident diabetes. A 1-unit increase in log-aldosterone was associated with a 44% higher risk of diabetes (HR 1.44, 95%CI 1.25-1.64). BP and glucose mediated 16.3% (95% CI: 7.0%, 31.0%) and 19.7% (95% CI: 6.5%, 34.0%) of the association of aldosterone with incident diabetes, respectively.

Conclusion: Aldosterone is a mediator of the association of ICH with incident diabetes, whereas BP and glucose are mediators of the association of aldosterone with incident diabetes, emphasizing the importance of the renin-angiotensin-aldosterone system and ICH in lowering risk of diabetes in AA populations.

Citing Articles

The Association of Adiposity and RAAS With Incident Diabetes in African Americans: The Jackson Heart Study.

Nedungadi D, Ayodele Adesanya T, Rayan M, Zhao S, Williams A, Brock G J Clin Endocrinol Metab. 2024; 110(1):151-158.

PMID: 38885313 PMC: 11651680. DOI: 10.1210/clinem/dgae396.


Associated lifestyle factors of elevated plasma aldosterone concentration in community population, gender-stratified analysis of a cross-sectional survey.

Maitituersun A, Heizhati M, Li N, Gan L, Li M, Yao L BMC Public Health. 2024; 24(1):1370.

PMID: 38773424 PMC: 11110359. DOI: 10.1186/s12889-024-18796-0.


The association of aldosterone and endothelin-1 with incident diabetes among African Americans: The Jackson Heart Study.

Joseph J, Kluwe B, Zhao S, Kline D, Nedungadi D, Brock G Endocr Metab Sci. 2023; 11.

PMID: 37475850 PMC: 10358435. DOI: 10.1016/j.endmts.2023.100128.


Silver-functionalized bismuth oxide (AgBiO) nanoparticles for the superior electrochemical detection of glucose, NO and HO.

Ramesh M, Sankar C, Umamatheswari S, Ganapathi Raman R, Jayavel R, Choi D RSC Adv. 2023; 13(30):20598-20609.

PMID: 37441044 PMC: 10333811. DOI: 10.1039/d2ra08140g.


The role of aldosterone and ideal cardiovascular health in incident cardiovascular disease: The Jackson heart study.

Kluwe B, Pohlman N, Kesireddy V, Zhao S, Tan Y, Kline D Am J Prev Cardiol. 2023; 14:100494.

PMID: 37114212 PMC: 10126856. DOI: 10.1016/j.ajpc.2023.100494.

References
1.
Effoe V, Carnethon M, Echouffo-Tcheugui J, Chen H, Joseph J, Norwood A . The American Heart Association Ideal Cardiovascular Health and Incident Type 2 Diabetes Mellitus Among Blacks: The Jackson Heart Study. J Am Heart Assoc. 2017; 6(6). PMC: 5669153. DOI: 10.1161/JAHA.116.005008. View

2.
Raghavan S, Porneala B, McKeown N, Fox C, Dupuis J, Meigs J . Metabolic factors and genetic risk mediate familial type 2 diabetes risk in the Framingham Heart Study. Diabetologia. 2015; 58(5):988-96. PMC: 4393775. DOI: 10.1007/s00125-015-3498-7. View

3.
Tucker K, Maras J, Champagne C, Connell C, Goolsby S, Weber J . A regional food-frequency questionnaire for the US Mississippi Delta. Public Health Nutr. 2005; 8(1):87-96. View

4.
Sowers J, Whaley-Connell A, Epstein M . Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med. 2009; 150(11):776-83. PMC: 2824330. DOI: 10.7326/0003-4819-150-11-200906020-00005. View

5.
Brown N . Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol. 2013; 9(8):459-69. PMC: 3922409. DOI: 10.1038/nrneph.2013.110. View